Vimarsana
Biggest News Aggregation in the World

Preeya Gupta News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Preeya Gupta. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Preeya Gupta Today - Breaking & Trending Today

ASCRS 2024: Refractive cataract surgery in DED afflicted eyes - Vimarsana News

ASCRS 2024: Refractive cataract surgery in DED afflicted eyes

Jennifer Loh, MD, sat down to discuss her presentation on major eye issues that can interfere with refractive cataract surgery, specifically dry eye disease, at this year's ASCRS meeting held in Boston, Massachusetts.

Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S. - Vimarsana News

Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S.

BERWYN, Pa.--(BUSINESS WIRE)--Jan 15, 2024--

Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S. - Vimarsana News

Nordic Group B.V. Through Its Subsidiary Amring Pharmaceuticals Inc., Announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S.

Amring Pharmaceuticals Inc. (Amring), a subsidiary of Nordic Group B.V. (Nordic Pharma), announces Jai G. Parekh, MD, MBA as Chief Commercial Officer, Eye Care U.S. Nordic Pharma recently expanded its pharmaceutical expertise in the U.S. by...

FDA Approves Perfluorohexyloctane Ophthalmic Solution for Dry Eye Disease - Vimarsana News

FDA Approves Perfluorohexyloctane Ophthalmic Solution for Dry Eye Disease

The approval marks the first and only FDA-approved treatment for dry eye disease that directly targets tear evaporation.

Bausch + Lomb Corporation: Bausch + Lomb and Novaliq Announce FDA Approval of MIEBO (Perfluorohexyloctane Ophthalmic Solution) for the Treatment of the Signs and Symptoms of Dry Eye Disease - Vimarsana News

Bausch + Lomb Corporation: Bausch + Lomb and Novaliq Announce FDA Approval of MIEBO (Perfluorohexyloctane Ophthalmic Solution) for the Treatment of the Signs and Symptoms of Dry Eye Disease

MIEBO is the First and Only Prescription Eye Drop Approved for Dry Eye Disease that Directly Targets Tear Evaporation, Based on Consistent Results from Two Consecutive Pivotal Phase 3 Trials Bausch